Shares rose after the eye-care specialist reported an acceleration in sales growth and confirmed its annual outlook, reassuring on its prospects after two guidance cuts this year.
Source link
Shares rose after the eye-care specialist reported an acceleration in sales growth and confirmed its annual outlook, reassuring on its prospects after two guidance cuts this year.
Source link